MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

Brodalumab Meets Primary Endpoint in Plaque Psoriasis Trial

Amgen and AstraZeneca announced results from the Phase 3 AMAGINE-2 study evaluating two doses of brodalumab in patients with moderate-to-severe plaque psoriasis.

70% of HIV Infections Not Under Control, Says CDC

According to a new Vital Signs report by the Centers for Disease Control and Prevention (CDC), only 30% of Americans with HIV had the virus under control in 2011, and about two-thirds of those with the virus not in control had been diagnosed but were no longer in care.

Weight Loss Caps Contain Withdrawn Drug

The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-Vie, a supplement marketed for weight loss.

Rare Brain Infection May Be Linked to MS Drug

The FDA has issued a warning about one patient with multiple sclerosis (MS) being treated with Tecfidera (dimethyl fumarate; Biogen Idec) who developed progressive multifocal leukoencephalopathy (PML) and later died.

FDA Finalizes Rules on Calorie Info Display

As required by the 2010 Patient Protection and Affordable Care Act, the FDA finalized that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments, and vending machines with 20 or more locations.